The United States Food and Drug Administration has approved FDAWith a new HIV injection called Sunlinka sunlenca an injectable treatment to suppress HIV, for patients with other drug-resistant systems.
Experts have pointed out that the new injections, which work at lower doses in the number of times they are taken, could be a game-changer for those who have not responded to other treatments..
According to the site Doctor ExpressThis drug was developed by Gilead Sciences of Gilead It is the first in a new class called capsid inhibitors, which work by blocking the protein envelope or preventing the virus from replicating and reducing the viral load, which leads to the disruption of multiple stages of the virus life cycle, explaining that in the trial clinic, 83% of patients who took the injections sunlenca With a combination of other drugs a small viral load is undetectable after about a year.
What is Sunlenca’s HIV treatment?
sunlenca or lenacapavir It is the first in a new class of drugs approved by the US Food and Drug Administration. FDA“to cure HIV” AIDS“.
The site added that the drug linacabavir Lenacapavir Sunlinka is an antiretroviral drug that works by stopping the virus from multiplying to keep the levels of HIV in the body very low..
Sunlinka approved sunlenca For patients infected with the human immunodeficiency virus “AIDS” whose infection has not responded to other multiple drug regimens, treatment begins with a system of oral tablets and injections, then continuous injections every 6 months..
